Quizartinib is a Type II FLT3 Tyrosine Kinase Inhibitor for AML Research
FLT3 (Fms-like tyrosine kinase 3, CD135) is a cytokine receptor which belongs to the receptor tyrosine kinase class III. Besides, FLT3 is important for the normal development of stem cells and…